Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 189articles · 30d
- 8+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- HTH 139
- HW 102
- economy business and finance 81
- health 75
- BI 65
- FIB 33
- science and technology 21
- NW 15
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Molbio Diagnostics swings to profit in Q1 FY27 as Truenat test-kit volumes surge
5+ day, 10+ hour ago (65+ words) India continued to account for the majority of Molbio's business, contributing 83.52% of revenue, while exports accounted for 16.48% Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership to…...
Dr. Rajesh Nair appointed CEO of Park Group of Hospitals
1+ week, 6+ day ago (185+ words) Park Group of Hospitals has appointed Dr. Rajesh Nair as Chief Executive Officer, strengthening its leadership team with an accomplished healthcare professional. In his new role, Dr. Nair will be responsible for driving operational excellence, strengthening strategic initiatives and supporting…...
DoP's second PRIP call offers up to Rs. 100 crore per project for pharma and MedTech innovation
2+ week, 1+ day ago (414+ words) Rs. 5,000-crore scheme invites applications from startups, MSMEs and industry across new medicines, biosimilars, novel medical devices and other priority areas The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has announced the second call for applications under the…...
India’s genomics leaders to join Indian Pharma Post E-Conference on August 26
2+ week, 6+ day ago (288+ words) and personalised healthcare. The Indian genomics market, valued at approximately US$2.5 billion in 2025,...
Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push
1+ week, 5+ day ago (65+ words) Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push on US drug pricing…...
Roche Pharma India names five winners of third edition of LEAP Oncology programme
5+ day, 18+ hour ago (442+ words) Roche Pharma India has announced the winners of the third edition of its Leading Engagements to Advance Patient Care (LEAP) programme, recognising five oncology students for developing innovative solutions to challenges in cancer care. The third edition of LEAP invited…...
Pfizer and BioNTech bag FDA nod for XFG-targeted COVID-19 vaccine
1+ week, 6+ day ago (75+ words) The vaccine is not appropriate for people who have experienced a severe allergic reaction after a previous dose of COMIRNATY Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a…...
India Health 2026 opens in New Delhi, showcasing healthcare and MedTech innovation
3+ week, 17+ hour ago (470+ words) 2030, while the country's medical tourism market is projected to grow from US$8.71 billion in 2025...
Tech Mahindra partners with PeaceHealth to modernize healthcare IT operations in US
5+ day, 18+ hour ago (216+ words) Tech Mahindra, a global technology consulting and digital solutions provider, has partnered with PeaceHealth, a US-based faith-based not-for-profit health system, to modernize and manage key technology operations as part of the healthcare provider’s long-term digital transformation strategy. Under the partnership,…...
AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%
6+ day, 1+ hour ago (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...